Guy S. Salvesen, Annalisa M. VanHook
Abstract
Arsenic trioxide treatment switches which SUMO variant is conjugated to an oncoprotein, thus triggering its degradation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Arsenic trioxide treatment switches which SUMO variant is conjugated to an oncoprotein, thus triggering its degradation.
Key concepts: Arsenic trioxide, Cancer research, Cell biology, Degradation (telecommunications), Chemistry, Medicine, Biology, Computer science